Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia [clinicaltrials:NCT01079507]
Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia [clinicaltrials:NCT01079507]
Bio2RDF identifier
NCT01079507
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT01079507
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
biospec retention [clinicaltrials_vocabulary:biospec-retention]
Samples With DNA
biospec_descr [clinicaltrials_vocabulary:biospec_descr]
Stored bone marrow specimens of patients with acute lymphoblastic leukemia
brief summary [clinicaltrials_vocabulary:brief-summary]
Acute lymphoblastic leu ...... enetic research in the world.
brief title [clinicaltrials_vocabulary:brief-title]
Genome-wide Single Nucleotide ...... h Acute Lymphoblastic Leukemia
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2010-03-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
adult acute lymphoblastic leukemia
single nucleotide polymorphism
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2010-03-02T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT01079507
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Genome-wide Single Nucleotide ...... h Acute Lymphoblastic Leukemia
org study id [clinicaltrials_vocabulary:org-study-id]
2009-06-060
overall contact [clinicaltrials_vocabulary:overall-contact]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2010-02-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2010-03-01T00:00:00Z
identifier
clinicaltrials:NCT01079507
title
Genome-wide Single Nucleotide ...... h Acute Lymphoblastic Leukemia
@en
type
label
Genome-wide Single Nucleotide ...... a [clinicaltrials:NCT01079507]
@en